Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $671.5M
Liabilities Breakdown FY2021
Total Liabilities: $226.0M
Asset Breakdown
Total Assets: $671.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $126.4M | 18.8% |
| Accounts Receivable | $78.8M | 11.7% |
| Inventory | $92.8M | 13.8% |
| Property, Plant & Equipment | $244.2M | 36.4% |
| Goodwill | $3.3M | 0.5% |
| Intangible Assets | $6.3M | 0.9% |
| Other Assets | $119.7M | 17.8% |
Liabilities Breakdown
Total Liabilities: $226.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $22.2M | 9.8% |
| Long-Term Debt | $78.2M | 34.6% |
| Other Liabilities | $125.6M | 55.6% |